PATENT CLAIM ANALYSIS

Application Number: 15756483
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "002400"]

Abstract:
Disclosed are synthetic peptides and peptide compositions, including peptide conjugates, that can ameliorate and/or block the cytotoxicity of  C. difficile  TcdB toxin, and methods of their use for inhibiting the activity of TcdB and protecting against damage during  C. difficile  disease, and/or for use as cell penetrating peptides for enhancing the delivery of particular heterogenous molecules into cells.

Claim (Index 19):
The pharmaceutical composition of  claim 10 , comprising a formulation for extended release of the peptide.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.43182
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10196394', '13262186', '15119058', '14005135', '10202915']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7942738362599981
- 35 USC 102 Novelty (BERT): 0.5337047362242157
- Combined Prediction Score: 0.7682169262564199
- Mean Citation Score: 370.798698
- Max Citation Score: 375.74005
- Similarity Product: 213.45159760133623

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test